/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Masanobu Takahashi

Yamagata University(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

372

Papers

8.9K

Citations

33

h-index

91

i10-index

Masanobu Takahashi is an academic researcher from Yamagata University. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Cancer Immunotherapy and Biomarkers & Colorectal Cancer Treatments and Studies. The author has an h-index of 33, co-authored 317 publications.

Research Topics

Gastric Cancer Management and Outcomes Cancer Immunotherapy and Biomarkers Colorectal Cancer Treatments and Studies Esophageal Cancer Research and Treatment Genetic factors in colorectal cancer

Papers by this author

works

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

2019 · The Lancet Oncology · 1,196 citations

https://doi.org/10.1016/s1470-2045(19)30626-6

Ken Kato Byoung Chul Cho Masanobu Takahashi Morihito Okada

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis

2012 · Gut · 543 citations

https://doi.org/10.1136/gutjnl-2011-301846

Keun Hur Yuji Toiyama Masanobu Takahashi Francesc Balaguer

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer

2023 · ESMO Open · 66 citations

https://doi.org/10.1016/j.esmoop.2023.101558

Takayuki Yoshino Andrés Cervantes Hideaki Bando Erika Martinelli

Weight quantization in Boltzmann machines

1991 · Neural Networks · 50 citations

https://doi.org/10.1016/0893-6080(91)90077-i

Wolfgang Balzer Masanobu Takahashi Jun Ohta Kazuo Kyuma

Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)

2020 · Esophagus · 43 citations

https://doi.org/10.1007/s10388-020-00794-x

Masanobu Takahashi Ken Kato Morihito Okada Keisho Chìn

Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei

2019 · International Journal of Clinical Oncology · 23 citations

https://doi.org/10.1007/s10147-019-01592-x

Sakura Hiraide Keigo Komine Yuko Sato Kota Ouchi

Research topics

topics

Gastric Cancer Management and Outcomes

Cancer Immunotherapy and Biomarkers

Colorectal Cancer Treatments and Studies

Esophageal Cancer Research and Treatment

Genetic factors in colorectal cancer

Chat about Author

Papers

Chat

Click to start Chat